Cargando…
Immunization with the HisAK70 DNA Vaccine Induces Resistance against Leishmania Amazonensis Infection in BALB/c Mice
Leishmania amazonensis is the aetiological agent of a broad spectrum of leishmaniosis in South America. It can cause not only numerous cases of cutaneous leishmaniosis but also diffuse cutaneous leishmaniosis. Considering the diversity of parasite species causing different forms of the disease that...
Autores principales: | Martínez-Rodrigo, Abel, S. Dias, Daniel, Ribeiro, Patrícia A. F., Roatt, Bruno M., Mas, Alicia, Carrión, Javier, Coelho, Eduardo A. F., Domínguez-Bernal, Gustavo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963319/ https://www.ncbi.nlm.nih.gov/pubmed/31739549 http://dx.doi.org/10.3390/vaccines7040183 |
Ejemplares similares
-
HisAK70: progress towards a vaccine against different forms of leishmaniosis
por: Domínguez-Bernal, Gustavo, et al.
Publicado: (2015) -
Transcriptional signatures of BALB/c mouse macrophages housing multiplying Leishmania amazonensis amastigotes
por: Fortéa, José Osorio y, et al.
Publicado: (2009) -
Phenotypic diversity and selection maintain Leishmania amazonensis infectivity in BALB/c mouse model
por: Espiau, Benoît, et al.
Publicado: (2017) -
Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis
por: Viana, Sayonara M., et al.
Publicado: (2018) -
Pharmacokinetics of neutron-irradiated meglumine antimoniate in
Leishmania amazonensis-infected BALB/c mice
por: Borborema, Samanta Etel Treiger, et al.
Publicado: (2019)